Accounts Receivable, after Allowance for Credit Loss, Current of Zhong Yuan Bio-Technology Holdings Ltd from 31 Mar 2019 to 31 Mar 2024

Taxonomy & unit: us-gaap: USD
Description: Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary: Zhong Yuan Bio-Technology Holdings Ltd quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 31 Mar 2019 to 31 Mar 2024.
Zhong Yuan Bio-Technology Holdings Ltd Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Mar 2024 was $790,626, a 124% increase year-over-year.
Source SEC data: View on sec.gov

Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)

Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

Zhong Yuan Bio-Technology Holdings Ltd Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2024	$790,626	+$436,923	+124%	31 Mar 2024	20-F	07 Nov 2024	2024	FY
Q1 2023	$353,703	+$159,565	+82%	31 Mar 2023	20-F	07 Nov 2024	2024	FY
Q1 2022	$194,138	-$70,611	-27%	31 Mar 2022	20-F	07 Nov 2024	2024	FY
Q1 2021	$264,749	-$65,142	-20%	31 Mar 2021	20-F	07 Nov 2024	2024	FY
Q1 2020	$329,891	-$33,600	-9.2%	31 Mar 2020	20-F	16 Aug 2021	2021	FY
Q1 2019	$363,491			31 Mar 2019	20-F	17 Aug 2020	2019	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.